NETWORK IMMUNOLOGY
Network Immunology is a biotechnology company that develops novel immunotherapies for inflammatory diseases.
NETWORK IMMUNOLOGY
Industry:
Biotechnology Medical Therapeutics
Founded:
2003-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.networkimmunology.com
Total Employee:
11+
Status:
Active
Contact:
+1-778-847-7521
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GoDaddy DNS YouTube Google
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
ImmunePath
ImmunePath is a biotechnology company that develops stem cell based therapeutics based in Menlo Park, California.
Protomer Technologies
Protomer Technologies is a biotechnology company that focuses on metabolic diseases.
Official Site Inspections
http://www.networkimmunology.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Network Immunology"
NETWORK IMMUNOLOGY (Copy)
Network Immunology is shifting how the world sees the immune system. Using immune network theory as our foundation, we’re harnessing our Nobel Prize winning science to transform groundbreaking immunological research into real …See details»
Network Immunology - PitchBook
Developer of novel therapies designed for the treatment of inflammatory diseases. The company helps to develop a preventive HIV vaccine and an HIV therapeutic, thereby enabling …See details»
Network Immunology Company Profile | Management and
Network Immunology Profile and History . Founded in 2003, Network Immunology Inc. is a privately held Vancouver-based preclinical stage biotechnology company focused on …See details»
Network Immunology - Overview, News & Similar companies
Network Immunology contact info: Phone number: (778) 846-7521 Website: www.networkimmunology.com What does Network Immunology do? Founded in 2003, …See details»
Network Immunology - LinkedIn
Network Immunology Inc. ("NI") is a leading edge, Vancouver based biotech company developing a revolutionary immunotherapeutic platform called AbstimX™. Treatment with AbstimX™ re …See details»
Network Immunology Inc. | Vancouver, BC, Canada …
Revolutionary platform immuno-therapy for inflammatory autoimmune and allergic diseases. Network Immunology has a platform technology for the treatment of allergies. As a first step, we are focused on solving the enormous global …See details»
Network Immunology - Crunchbase Company Profile …
Network Immunology is a biotechnology company that develops novel immunotherapies for inflammatory diseases. There is no recent news or activity for this profile. View contacts for Network Immunology to access new leads …See details»
Network Immunology Inc. (formerly Hoffman Technologies Inc.)
Website: https://www.networkimmunology.com. Network Immunology Inc. is a privately held Vancouver based biotechnology company, founded in 2003. The Company is developing, and …See details»
Network Immunology Inc - Vancouver, BC | Vancouver Local
Products & Services. animal health , communications , partnership possibilities , inflammatory diseases , brand development , chronic inflammatory diseases treatment , innovative therapy …See details»
Network Immunology, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Network Immunology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:MAB3 Network Immunology.See details»
Network Immunology - Products, Competitors, Financials, …
Network Immunology focuses on developing immunotherapeutic solutions within the biotech industry. The company specializes in a platform therapy known as AbstimX™ that aims to …See details»
Network Immunology - Company Profile - Tracxn
Oct 21, 2024 · Network Immunology is a Canadian, preclinical biotech developing immunotherapies for inflammatory diseases and cancer. It is developing its lead …See details»
Network Immunology Inc. | Vancouver, BC, Canada Startup - Gust
Network Immunology Inc. is a privately held biotech company that develops patented immuno-therapeutics. Our breakthrough treatment is AbstimX which we believe has the possibility to be …See details»
George Hoffmann - Chairman and CEO - Network Immunology
Chairman at Network Immunology Inc. Platform Technology for the Treatment of Chronic Inflammatory Diseases | Allergy | Autoimmunity | Enhancement of the Adaptive Immune …See details»
Network Immunology, 3311 Quesnel Dr, Vancouver, BC - MapQuest
Get more information for Network Immunology in Vancouver, BC. See reviews, map, get the address, and find directions.See details»
Network Immunology Inc. - Facebook
Network Immunology Inc. 257 likes · 1 was here. The mission of Network Immunology is to enhance and prolong the quality of lives - of us humans, and our...See details»
The latest R&D info about Network Immunology, Inc.: pipelines, …
Find drug R&D information for Network Immunology, Inc.. including drug pipeline ... Network Immunology, Inc. has a total of 4 Literature ...See details»
An introduction to immunology and immunopathology - PMC
Beyond structural and chemical barriers to pathogens, the immune system has two fundamental lines of defense: innate immunity and adaptive immunity. Innate immunity is the first …See details»
Network biology: understanding the cell's functional organization
Feb 1, 2004 · Here, we review the present knowledge of the design principles for the structure and system-scale function of cellular networks, and the evolutionary mechanisms that might …See details»
Mapping spatial organization and genetic cell-state regulators to ...
Aug 23, 2024 · To this end, we first mapped the spatial organization of high-grade serous tubo-ovarian cancer by profiling more than 2.5 million cells in situ in 130 tumors from 94 patients.See details»